Baxter Healthcare Corporation recalls Cefazolin in Dextrose
- Recalling company
- Baxter Healthcare Corporation
- Product
- Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.
- Reason
- Presence of Particulate Matter
- Classification
- Class I – a reasonable probability that use will cause serious adverse health consequences or death
- Recall date
- Jul 24, 2026
- Reported
- Aug 19, 2026
- Distribution
- US Nationwide.
- Status
- Ongoing
- Quantity
- 19,032 bags
- Lot / codes
- Lot # LD175708, Exp Date: 14-Feb-2027.
- Company location
- Deerfield, IL
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0787-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0787-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.